A comparative study of the effects of anti-parkinson drugs on the oxotremorine-induced EEG and muscular activities.
D000818:Animals; D004155:Diphenhydramine / Q000494:pharmacology; D004336:Drug Antagonism; D004569:Electroencephalography; D008297:Male; D009129:Muscle Tonus / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009966:Orphenadrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010300:Parkinson Disease / Q000188:drug therapy; D011413:Propantheline / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011760:Pyrrolidinones / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011817:Rabbits; D012601:Scopolamine / Q000494:pharmacology; D013035:Spasm / Q000139:chemically induced; D014203:Tremorine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014282:Trihexyphenidyl / Q000494:pharmacology
D010276:Parasympatholytics; D011760:Pyrrolidinones; D011413:Propantheline; D014282:Trihexyphenidyl; D004155:Diphenhydramine; D011433:Propranolol; D009966:Orphenadrine; D012601:Scopolamine; D014203:Tremorine